On December 14, Skadden presented the second session in our “Pharmaceutical and Medical Device Webinar Series”: “HHS-OIG: A Review of Recent Developments.” Life sciences and health care partner John Bentivoglio and litigation counsel Avia Dunn served as panelists. Topics included trends in the Office of the Inspector General’s use of corporate integrity agreements (CIAs) and the evolution of key CIA provisions regarding compliance program structure; and oversight, commercial and medical risk areas, risk assessment activities, and monitoring and auditing programs.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates